Sign in to view content

Tarcocimab Tedromer (KSI-301) Anti-VEGF Antibody Biopolymer Conjugate for DME: First-Time Efficacy, Durability and Safety Results of the GLEAM and GLIMMER Phase 3 studies

Charles C Wykoff, MD, PhD, FASRS

Video
Published 2023

Related

Anti-VEGF treatment switch in DME and nAMD: a comparison of aflibercept versus ranibizumab after a single-dose switch
Estephania Feria, MD
On Demand Cases, Courses, and Papers
2019
Episode 158: Journal Club with Dr. Ajay Kuriyan and Dr. Shriji Patel, IVR versus IVA for wet AMD, Protocol T subanalysis, CSR natural history
Jayanth Sridhar, MD
Member Podcasts
2018
One-Year Results of Fluocinolone Acetonide Intravitreal Implant For Diabetic Macular Edema in Highly Treated Eyes
Sumit P. Shah, MD, FACS, FASRS
On Demand Cases, Courses, and Papers
2017

Category: Diabetic Retinopathy

See more